Wall Street analysts currently rate Oscar Health (OSCR) as a cautious “Hold” with a consensus 12-month price target near ($18) to ($20), reflecting mixed sentiment following a period of high volatility. While the company recently posted record profits and reaffirmed strong full-year 2026 revenue guidance, the stock carries significant risks tied to the future of ACA insurance subsidies.
1. 🚨Investing Pro:
2.⏰ LPP 3.0 (Daily Live Trading):
3. 📸 Instagram:
4.🔥Wall Art That Fuels Your Motivation:
5.đź“Š Moomoo (Nvda Bonus):
#marketcrash #federalreserve #stockmarketnews #trumpnews #inflationreport #fomcmeeting #cpi #fedmeeting #jeromepowell #stockmarketlive #ratedecision #fomc #oilnews #brentoil #irannews #tsla #tesla #elonmusk #earningsreport #oscr #healthcare
Thank you for the support, the best way to reach out to me is through our private discord chat, please DM me.
source
